RecruitingNCT06515366

MAP( Mean Arterial Pressure) and Mortality Relation in Patients With Heart Failure

Evaluation of the Relationship Between Mean Arterial Pressure (MAP) and Mortality in Patients With Heart Failure: A Perspective From Emergency Department Monitoring and Hospital Presentation

Sponsor

Saglik Bilimleri Universitesi

Enrollment

280 participants

Start Date

Jun 1, 2024

Study Type

OBSERVATIONAL

Conditions

Heart Failure

Summary

Aim of this observational study is to evaluate the relationship between mean arterial pressure (MAP) and mortality in patients presenting to the emergency department with acute heart failure, focusing on emergency department monitoring and subgroup presentations. Our goal is to determine the impact of subgroup characteristics on mortality among patients presenting with heart failure in the emergency department, and to assess the predictive value and significance of MAP in predicting mortality.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This observational study is examining whether mean arterial pressure (MAP) — a measure of average blood pressure across the heart's pumping cycle — is a useful predictor of death in patients admitted to the hospital with heart failure. **You may be eligible if...** - You are 18 or older - You are presenting to the hospital with symptoms of heart failure **You may NOT be eligible if...** - You are under 18 years old - You are presenting with an ST-elevation heart attack (STEMI) - You have acute kidney failure - You are pregnant - The data required for the study is inaccessible in your medical record Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Etlik City Hospital

Ankara, Yenimahalle, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06515366

Related Trials

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

NCT06935370638 locations

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

NCT06424288653 locations

Impact of Optimized Pacing Strategies on Clinical and Hemodynamic Outcomes in Heart Failure Patients With Pacemaker

NCT075631531 location

A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

NCT06991257135 locations

HARMONY Trial : To Evaluate a Therapeutic and Monitoring Device(NOVAtria System) for Heart Failure Management

NCT074022391 location